Insider · CIK 0001960165
Stephen Wargacki
officer
Files at AQST (Aquestive Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | AQST Aquestive Therapeutics, Inc. | AGrant or award Common Stock | +115,000 | $0.00 | $0 | 376,414 | Mar 11, 2025 |
| Mar 7, 2025 | AQST Aquestive Therapeutics, Inc. | FTax withholding Common Stock | -12,859 | $2.65 | $34k | 363,555 | Mar 11, 2025 |
| Mar 9, 2025 | AQST Aquestive Therapeutics, Inc. | FTax withholding Common Stock | -15,431 | $2.65 | $41k | 348,124 | Mar 11, 2025 |
| Mar 10, 2025 | AQST Aquestive Therapeutics, Inc. | FTax withholding Common Stock | -4,572 | $2.54 | $12k | 343,552 | Mar 11, 2025 |
| Mar 7, 2025 | AQST Aquestive Therapeutics, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +65,000 | $0.00 | $0 | 65,000 | Mar 11, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.